present

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two…

1 day ago

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

April 13, 2026 09:00 ET  | Source: Senti Biosciences, Inc. SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) --…

1 day ago

Segway Powersports to Present Flagship Super Villain SX20T and AT10 W MUD at 139th Canton Fair

GUANGZHOU, China, April 10, 2026 /PRNewswire/ -- Segway Powersports, a global innovator in intelligent off-road vehicles and connected riding systems,…

4 days ago

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

March 20, 2026 13:30 ET  | Source: SANUWAVE Health, Inc. EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave…

4 weeks ago

NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026

March 10, 2026 08:05 ET  | Source: NKGen Biotech, Inc. SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen…

1 month ago

Surgery Partners, Inc. to Present at Upcoming Investor Conference

March 09, 2026 12:04 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners,…

1 month ago

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with…

1 month ago

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026

March 02, 2026 13:16 ET  | Source: RadNet, Inc. LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:…

1 month ago

argenx to Present at TD Cowen 46th Annual Healthcare Conference

February 23, 2026 01:00 ET  | Source: argenx SE February 23, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…

2 months ago

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA…

2 months ago